Catherine B Driver, MD
Rheumatology · Mission Viejo
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 6
Offices
6 locations · Providence Medical Foundation · 1,461 clinicians in this group
Hospitals listed: Providence Mission Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Driver’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A86522 · Current
Licensed to practise in California · since 2004 · expires 2028-04-30 · Jefferson Medical College of Thomas Jefferson University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Providence Mission HospitalMission Viejo, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.311, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.396, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.142, Oct 2024 – Sep 2025Better than the national rate — Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies): 10.4 (8.3 to 12.9) · 3,901 cases, Jan 2022 – Dec 2024
See every measure and the patient survey for Providence Mission Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 4 the same, 0 worse of 7 measures. Readmissions: 2 better, 9 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.311 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.396 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.142 | Better | Oct 2024 – Sep 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 10.4 (8.3 to 12.9) · 3,901 cases | Better | Jan 2022 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.29 (0.4 to 2.18) · 1,814 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.66 to 1.19) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 163.98 (122.65 to 205.3) · 165 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 56 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.7 · 80 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 273 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.8 · 434 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.7 · 962 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11 · 486 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 4,977 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.03 to 0.41) · 8,625 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.11 to 0.47) · 8,755 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.82 (1.09 to 4.54) · 2,413 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.24 (0.77 to 3.71) · 932 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.26 (0.9 to 3.61) · 2,222 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.47 (5.01 to 15.93) · 872 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.72 (2.6 to 8.84) · 861 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.57 (0.13 to 3.02) · 610 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 0.74) · 7,316 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.8 · 58 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.479 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 354 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.4 · 649 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 4.8 · 265 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 35.8 · 486 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 5.5 · 994 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.2 · 1,371 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.8 (3.4 to 6.8) · 209 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.1 (8.5 to 14.3) · 209 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 65 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.5 · 65 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 127 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 791 cases | No different | Jan 2024 – Dec 2024 |
What patients said (474 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$89,148
Medicare paid this office $89,148 for 270 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 228 | $51,601 | $102 |
| Long return visit (40+ min) | 77 | $14,080 | $142 |
| New patient visit (60+ min) | 38 | $6,758 | $178 |
| Aspiration and/or injection of fluid from large joint | 27 | $5,025 | $65 |
| Aspiration and/or injection of fluid from small joint | 16 | $1,118 | $45 |
See all 12 services
| Return visit (30+ min) | 228 | $51,601 | $102 |
| Long return visit (40+ min) | 77 | $14,080 | $142 |
| New patient visit (60+ min) | 38 | $6,758 | $178 |
| Aspiration and/or injection of fluid from large joint | 27 | $5,025 | $65 |
| Aspiration and/or injection of fluid from small joint | 16 | $1,118 | $45 |
| Insertion of needle into vein for collection of blood sample | 22 | $190 | $9 |
| Blood test, comprehensive group of blood chemicals | 18 | $186 | $10 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 19 | $145 | $8 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 22 | $129 | None |
| Injection, methylprednisolone acetate, 1 mg | 21 | $114 | None |
| Measurement c-reactive protein for detection of infection or inflammation | 22 | $112 | $5 |
| Red blood cell sedimentation rate, to detect inflammation, automated | 22 | $58 | $3 |
Who their Medicare patients are
270 Original Medicare patients in 2024. Average age 76 · Women 86% · Health risk score 1.39. Above the middle of the specialty; the typical rheumatology clinician is at 1.38.
Conditions among them: High blood pressure 67% · Coronary heart disease 25% · Depression 21% · Diabetes 20% · Chronic kidney disease 16% · COPD 16% · Atrial fibrillation 16% · Cancer 13% · Heart failure 10% · Stroke 5% · Dementia 4%.
The office billed $359,984, Medicare allowed $119,047 and paid $89,148; for 2,525 services of 30 kinds; $8,121 of it was for drugs given in the office and $81,027 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 270 | 2,525 | 76 | 1.39 | $359,984 | $89,148 |
| 2023 | 257 | 66,823 | 75 | 1.34 | $1,783,571 | $558,605 |
| 2022 | 259 | 31,787 | 75 | 1.36 | $1,087,298 | $353,715 |
| 2021 | 291 | 32,973 | 74 | 1.34 | $1,108,421 | $486,748 |
| 2020 | 309 | 54,009 | 74 | 1.30 | $1,696,943 | $708,981 |
| 2019 | 307 | 30,975 | 74 | 1.29 | $1,096,259 | $455,193 |
| 2018 | 256 | 22,415 | 74 | 1.35 | $847,140 | $380,264 |
| 2017 | 247 | 27,687 | 74 | 1.35 | $1,121,051 | $477,610 |
| 2016 | 252 | 26,249 | 74 | 1.39 | $1,150,465 | $480,948 |
| 2015 | 239 | 20,690 | 74 | 1.42 | $1,034,002 | $446,085 |
| 2014 | 232 | 11,406 | 74 | 1.28 | $963,052 | $393,231 |
| 2013 | 237 | 8,355 | 74 | 1.33 | $644,726 | $282,734 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 18 services
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 11 | $139,136 | None |
| Return visit (30+ min) | 226 | $49,064 | $102 |
| Injection, denosumab, 1 mg | 24 | $43,946 | None |
| Long return visit (40+ min) | 61 | $12,016 | $140 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 21 | $5,117 | $58 |
| Aspiration and/or injection of fluid from large joint | 25 | $3,127 | $61 |
| Injection of drug or substance under skin or into muscle | 39 | $2,731 | $12 |
| New patient visit (60+ min) | 13 | $2,095 | $161 |
| Insertion of needle into vein for collection of blood sample | 68 | $1,193 | $8 |
| Blood test, comprehensive group of blood chemicals | 61 | $1,190 | $10 |
| Aspiration and/or injection of fluid from small joint | 14 | $949 | $41 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 57 | $860 | $8 |
| Measurement c-reactive protein for detection of infection or inflammation | 63 | $691 | $5 |
| Vitamin d-3 level | 19 | $580 | $29 |
| Measurement of complement (immune system proteins), antigen, | 15 | $435 | $12 |
| Red blood cell sedimentation rate, to detect inflammation, automated | 43 | $135 | $3 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 21 | $117 | None |
| Manual urinalysis test with examination using microscope, automated | 17 | $90 | $3 |
2022: 17 services
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 11 | $88,008 | None |
| Return visit (30+ min) | 205 | $43,043 | $102 |
| Long return visit (40+ min) | 74 | $16,435 | $157 |
| Injection, denosumab, 1 mg | 14 | $15,716 | None |
| New patient visit (60+ min) | 17 | $3,239 | $191 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 21 | $2,946 | $64 |
| Aspiration and/or injection of fluid from large joint | 20 | $2,455 | $65 |
| Injection of drug or substance under skin or into muscle | 35 | $1,521 | $13 |
| Blood test, comprehensive group of blood chemicals | 56 | $1,210 | $10 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 59 | $905 | $8 |
| Measurement c-reactive protein for detection of infection or inflammation | 59 | $630 | $5 |
| Vitamin d-3 level | 15 | $498 | $29 |
| Measurement of complement (immune system proteins), antigen, | 18 | $425 | $12 |
| Insertion of needle into vein for collection of blood sample | 72 | $412 | $3 |
| Injection, methylprednisolone acetate, 80 mg | 22 | $203 | None |
| Manual urinalysis test with examination using microscope, automated | 24 | $106 | $3 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 17 | $69 | None |
2021: 22 services
| Return visit (30+ min) | 227 | $48,142 | $104 |
| Injection, denosumab, 1 mg | 16 | $17,246 | None |
| Long return visit (40+ min) | 72 | $16,168 | $159 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 30 | $4,897 | $66 |
| Aspiration and/or injection of fluid from large joint | 25 | $3,650 | $51 |
| Administration of chemotherapy into vein, 1 hour or less | 13 | $3,083 | $128 |
| Injection of drug or substance under skin or into muscle | 45 | $1,565 | $13 |
| New patient visit (45+ min) | 12 | $1,526 | $127 |
| Short return visit (20+ min) | 15 | $1,401 | $82 |
| Administration of chemotherapy into vein, each additional hour | 13 | $992 | $28 |
| Blood test, comprehensive group of blood chemicals | 52 | $866 | $11 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $718 | $48 |
| Aspiration and/or injection of fluid from small joint | 13 | $637 | $42 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 50 | $629 | $8 |
| Measurement c-reactive protein for detection of infection or inflammation | 54 | $430 | $5 |
| Vitamin d-3 level | 12 | $355 | $30 |
| Measurement of complement (immune system proteins), antigen, | 14 | $336 | $12 |
| Insertion of needle into vein for collection of blood sample | 55 | $255 | $3 |
| Injection, methylprednisolone acetate, 80 mg | 20 | $242 | None |
| Red blood cell sedimentation rate, to detect inflammation, automated | 29 | $97 | $3 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 15 | $86 | None |
| Manual urinalysis test with examination using microscope, automated | 21 | $76 | $3 |
2020: 26 services
| Return visit (30+ min) | 231 | $38,814 | $86 |
| Injection, denosumab, 1 mg | 12 | $15,784 | None |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 12 | $8,086 | None |
| Administration of chemotherapy into vein, 1 hour or less | 20 | $6,813 | $131 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 31 | $6,455 | $67 |
| Aspiration and/or injection of fluid from large joint | 27 | $5,278 | $68 |
| New patient visit (60+ min) | 25 | $4,026 | $161 |
| Long return visit (40+ min) | 28 | $3,951 | $113 |
| Administration of chemotherapy into vein, each additional hour | 20 | $2,944 | $28 |
| Telephone medical discussion with physician, 11-20 minutes | 26 | $1,727 | $52 |
| Injection of drug or substance under skin or into muscle | 36 | $1,648 | $12 |
| Short return visit (20+ min) | 18 | $1,441 | $60 |
| New patient visit (45+ min) | 11 | $1,404 | $128 |
| Blood test, comprehensive group of blood chemicals | 56 | $1,008 | $10 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 55 | $749 | $8 |
| Injection of additional new drug or substance into vein | 13 | $721 | $15 |
| Vitamin d-3 level | 14 | $442 | $29 |
| Measurement of complement (immune system proteins), antigen, | 15 | $431 | $12 |
| Measurement c-reactive protein for detection of infection or inflammation | 51 | $417 | $5 |
| Insertion of needle into vein for collection of blood sample | 58 | $304 | $3 |
| Red blood cell sedimentation rate, to detect inflammation, automated | 53 | $228 | $3 |
| Blood test, lipids (cholesterol and triglycerides) | 15 | $200 | $13 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 12 | $158 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 17 | $124 | None |
| Manual urinalysis test with examination using microscope, automated | 19 | $82 | $3 |
| Injection, diphenhydramine hcl, up to 50 mg | 11 | $11 | None |
2019: 23 services
| Injection, infliximab, excludes biosimilar, 10 mg | 14 | $69,078 | None |
| Return visit (30+ min) | 246 | $45,596 | $89 |
| Injection, denosumab, 1 mg | 17 | $19,514 | None |
| Long return visit (40+ min) | 45 | $6,663 | $115 |
| Administration of chemotherapy into vein, 1 hour or less | 21 | $4,881 | $128 |
| Aspiration and/or injection of fluid from large joint | 30 | $3,320 | $66 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 17 | $3,277 | $67 |
| New patient visit (60+ min) | 17 | $3,076 | $181 |
| Administration of chemotherapy into vein, each additional hour | 21 | $1,976 | $28 |
| New patient visit (45+ min) | 11 | $1,490 | $135 |
| Injection of drug or substance under skin or into muscle | 28 | $1,389 | $15 |
| Blood test, comprehensive group of blood chemicals | 63 | $1,255 | $12 |
| Short return visit (20+ min) | 17 | $1,253 | $66 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 57 | $863 | $8 |
| Vitamin d-3 level | 21 | $677 | $32 |
| Measurement c-reactive protein for detection of infection or inflammation | 60 | $602 | $6 |
| Insertion of needle into vein for collection of blood sample | 75 | $397 | $3 |
| Red blood cell sedimentation rate, to detect inflammation, automated | 60 | $320 | $3 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 16 | $126 | None |
| Injection, methylprednisolone acetate, 80 mg | 12 | $116 | None |
| Manual urinalysis test with examination using microscope, automated | 24 | $114 | $3 |
| Injection, methylprednisolone acetate, 40 mg | 13 | $75 | None |
| Phosphate level | 11 | $57 | $5 |
2018: 19 services
| Return visit (30+ min) | 225 | $46,241 | $87 |
| Administration of chemotherapy into vein, 1 hour or less | 11 | $5,257 | $131 |
| New patient visit (60+ min) | 31 | $4,950 | $160 |
| Long return visit (40+ min) | 29 | $4,123 | $115 |
| Aspiration and/or injection of fluid from large joint | 25 | $2,790 | $57 |
| Administration of chemotherapy into vein, each additional hour | 11 | $1,893 | $28 |
| Blood test, comprehensive group of blood chemicals | 64 | $1,559 | $13 |
| Short return visit (20+ min) | 20 | $1,469 | $64 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 61 | $1,128 | $9 |
| Measurement c-reactive protein for detection of infection or inflammation | 60 | $795 | $6 |
| Vitamin d-3 level | 17 | $645 | $36 |
| Blood test, thyroid stimulating hormone (tsh) | 18 | $447 | $20 |
| Insertion of needle into vein for collection of blood sample | 73 | $435 | $3 |
| Red blood cell sedimentation rate, to detect inflammation, automated | 62 | $427 | $3 |
| Blood test, lipids (cholesterol and triglycerides) | 15 | $292 | $16 |
| Thyroxine (thyroid chemical), free | 14 | $175 | $11 |
| Manual urinalysis test with examination using microscope, automated | 26 | $154 | $4 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $92 | None |
| Injection, methylprednisolone acetate, 20 mg | 13 | $82 | None |
2017: 25 services
| Return visit (30+ min) | 212 | $45,279 | $87 |
| Administration of chemotherapy into vein, 1 hour or less | 11 | $7,347 | $129 |
| Aspiration and/or injection of fluid from large joint | 26 | $4,059 | $59 |
| Long return visit (40+ min) | 33 | $4,007 | $111 |
| New patient visit (60+ min) | 23 | $3,847 | $167 |
| New patient visit (45+ min) | 23 | $2,950 | $128 |
| Administration of chemotherapy into vein, each additional hour | 11 | $2,563 | $26 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 14 | $2,555 | $61 |
| Short return visit (20+ min) | 27 | $1,955 | $58 |
| Injection of drug or substance under skin or into muscle | 20 | $1,825 | $23 |
| Blood test, comprehensive group of blood chemicals | 63 | $1,641 | $13 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 64 | $1,285 | $10 |
| Measurement c-reactive protein for detection of infection or inflammation | 67 | $928 | $7 |
| Vitamin d-3 level | 21 | $876 | $40 |
| Aspiration and/or injection of fluid from small joint | 11 | $590 | $33 |
| Red blood cell sedimentation rate, to detect inflammation, automated | 68 | $495 | $4 |
| Insertion of needle into vein for collection of blood sample | 78 | $460 | $3 |
| Blood test, thyroid stimulating hormone (tsh) | 13 | $316 | $23 |
| Cyanocobalamin (vitamin b-12) level | 12 | $271 | $19 |
| Blood test, lipids (cholesterol and triglycerides) | 16 | $271 | $14 |
| Manual urinalysis test with examination using microscope, automated | 20 | $149 | $4 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 17 | $129 | None |
| Injection, methylprednisolone acetate, 80 mg | 12 | $129 | None |
| Rheumatoid factor analysis | 13 | $102 | $7 |
| Injection, methylprednisolone acetate, 40 mg | 16 | $98 | None |
2016: 24 services
| Return visit (30+ min) | 213 | $47,221 | $85 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 11 | $5,751 | None |
| Aspiration and/or injection of fluid from large joint | 37 | $5,428 | $65 |
| New patient visit (45+ min) | 32 | $4,412 | $138 |
| Long return visit (40+ min) | 29 | $4,405 | $119 |
| Short return visit (20+ min) | 43 | $4,102 | $63 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 15 | $3,127 | $65 |
| New patient visit (60+ min) | 13 | $1,950 | $150 |
| Blood test, comprehensive group of blood chemicals | 69 | $1,922 | $13 |
| Injection of drug or substance under skin or into muscle | 14 | $1,887 | $23 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 65 | $1,443 | $10 |
| Vitamin d-3 level | 22 | $909 | $40 |
| Red blood cell sedimentation rate, to detect inflammation, automated | 70 | $585 | $4 |
| Insertion of needle into vein for collection of blood sample | 79 | $536 | $3 |
| Aspiration and/or injection of fluid from small joint | 13 | $498 | $36 |
| Measurement c-reactive protein for detection of infection or inflammation | 41 | $387 | $7 |
| Blood test, thyroid stimulating hormone (tsh) | 11 | $251 | $21 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 23 | $224 | None |
| Blood test, lipids (cholesterol and triglycerides) | 12 | $197 | $14 |
| Manual urinalysis test with examination using microscope, automated | 21 | $144 | $4 |
| Injection, methylprednisolone acetate, 80 mg | 13 | $127 | None |
| Injection, methylprednisolone acetate, 40 mg | 17 | $76 | None |
| Injection, methylprednisolone acetate, 20 mg | 12 | $48 | None |
| Creatine kinase (cardiac enzyme) level, total | 11 | $47 | $4 |
2015: 20 services
| Return visit (30+ min) | 196 | $45,947 | $88 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 26 | $6,239 | $63 |
| Short return visit (20+ min) | 53 | $5,015 | $61 |
| New patient visit (45+ min) | 36 | $4,685 | $130 |
| Long return visit (40+ min) | 22 | $3,521 | $126 |
| Aspiration and/or injection of fluid from large joint | 20 | $3,029 | $62 |
| Administration of chemotherapy into vein, 1 hour or less | 12 | $2,562 | $128 |
| Blood test, comprehensive group of blood chemicals | 70 | $1,866 | $13 |
| Administration of chemotherapy into vein, each additional hour | 12 | $1,481 | $26 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 70 | $1,462 | $10 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 11 | $1,094 | $17 |
| Injection of drug or substance under skin or into muscle | 19 | $920 | $22 |
| Vitamin d-3 level | 16 | $632 | $39 |
| Red blood cell sedimentation rate, to detect inflammation, automated | 69 | $574 | $4 |
| Insertion of needle into vein for collection of blood sample | 77 | $541 | $3 |
| Blood test, thyroid stimulating hormone (tsh) | 14 | $381 | $22 |
| Injection, methylprednisolone acetate, 80 mg | 16 | $121 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $92 | None |
| Automated urinalysis test | 22 | $87 | $3 |
| Creatine kinase (cardiac enzyme) level, total | 12 | $58 | $5 |
2014: 21 services
| Return visit (30+ min) | 199 | $53,463 | $89 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 25 | $6,295 | $64 |
| Aspiration and/or injection of fluid from large joint | 29 | $5,239 | $49 |
| Short return visit (20+ min) | 42 | $4,072 | $63 |
| Administration of chemotherapy into vein, 1 hour or less | 11 | $3,368 | $120 |
| New patient visit (45+ min) | 24 | $3,335 | $139 |
| Long return visit (40+ min) | 21 | $3,158 | $121 |
| Blood test, comprehensive group of blood chemicals | 65 | $1,991 | $13 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 67 | $1,612 | $10 |
| Administration of chemotherapy into vein, each additional hour | 11 | $1,203 | $26 |
| Vitamin d-3 level | 27 | $1,148 | $40 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 14 | $1,140 | $17 |
| Aspiration and/or injection of fluid from small joint | 18 | $956 | $34 |
| Red blood cell sedimentation rate, to detect inflammation, automated | 71 | $670 | $4 |
| Insertion of needle into vein for collection of blood sample | 82 | $606 | $3 |
| Injection of drug or substance under skin or into muscle | 15 | $505 | $23 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 20 | $172 | None |
| Automated urinalysis test | 27 | $111 | $3 |
| Injection, methylprednisolone acetate, 80 mg | 18 | $105 | None |
| Injection, methylprednisolone acetate, 20 mg | 18 | $59 | None |
| Injection, methylprednisolone acetate, 40 mg | 11 | $28 | None |
2013: 25 services
| Return visit (30+ min) | 213 | $58,167 | $91 |
| Administration of chemotherapy into vein, 1 hour or less | 16 | $10,832 | $135 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 11 | $10,710 | None |
| Long return visit (40+ min) | 32 | $5,175 | $120 |
| Aspiration and/or injection of fluid from large joint | 36 | $4,735 | $62 |
| New patient visit (45+ min) | 30 | $4,221 | $141 |
| Blood test, comprehensive group of blood chemicals | 81 | $2,231 | $13 |
| Administration of chemotherapy into vein, each additional hour | 12 | $2,102 | $28 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 79 | $1,801 | $11 |
| Vitamin d-3 level | 32 | $1,605 | $40 |
| Aspiration and/or injection of fluid from small joint | 17 | $1,197 | $41 |
| Short return visit (20+ min) | 16 | $1,152 | $64 |
| Insertion of needle into vein for collection of blood sample | 102 | $750 | $3 |
| Red blood cell sedimentation rate, to detect inflammation, automated | 80 | $739 | $4 |
| Blood test, thyroid stimulating hormone (tsh) | 13 | $388 | $23 |
| Injection of drug or substance under skin or into muscle | 12 | $382 | $24 |
| Manual urinalysis test with examination using microscope, automated | 30 | $159 | $4 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 18 | $151 | None |
| Injection, methylprednisolone acetate, 80 mg | 22 | $123 | None |
| Creatine kinase (cardiac enzyme) level, total | 19 | $119 | $5 |
| Injection, methylprednisolone acetate, 20 mg | 26 | $100 | None |
| Uric acid level, blood | 14 | $90 | $4 |
| Automated urinalysis test | 16 | $61 | $3 |
| Injection, methylprednisolone acetate, 40 mg | 13 | $39 | None |
| Infusion, normal saline solution, 250 cc | 19 | $14 | None |
Drugs they prescribed that Part D paid
$611,693
Pharmacies billed $611,693 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (84 of 1,998) in 2024. Above the middle of the specialty; the typical rheumatology clinician is at 3%.
1,856 generic and fewer than 11 brand-name prescriptions · $611,693 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Humira(Cf) | 11 | $148,512 | $13,501 |
| Enbrel Sureclick | 17 | $119,563 | $7,033 |
| Olumiant | 12 | $32,350 | $2,696 |
| Hydroxychloroquine Sulfate | 365 | $12,078 | $33 |
| Methotrexate | 181 | $6,337 | $35 |
See all 33 drugs
| Humira(Cf) | 11 | $148,512 | $13,501 |
| Enbrel Sureclick | 17 | $119,563 | $7,033 |
| Olumiant | 12 | $32,350 | $2,696 |
| Hydroxychloroquine Sulfate | 365 | $12,078 | $33 |
| Methotrexate | 181 | $6,337 | $35 |
| Celecoxib | 113 | $2,896 | $26 |
| Leflunomide | 46 | $2,266 | $49 |
| Prednisone | 236 | $1,979 | $8 |
| Gabapentin | 108 | $1,592 | $15 |
| Diclofenac | 53 | $1,262 | $24 |
| Sulfasalazine | 29 | $1,235 | $43 |
| Duloxetine | 66 | $1,143 | $17 |
| Etodolac | 26 | $1,040 | $40 |
| Tramadol | 62 | $767 | $12 |
| Alendronate | 61 | $578 | $9 |
| Pregabalin | 24 | $571 | $24 |
| Leucovorin | 22 | $538 | $24 |
| Sulfasalazine Dr | 12 | $448 | $37 |
| Hydrocodone-Acetaminophen | 20 | $259 | $13 |
| Folic Acid | 22 | $251 | $11 |
| Nabumetone | 11 | $251 | $23 |
| Amitriptyline | 45 | $245 | $5 |
| Methylprednisolone | 51 | $239 | $5 |
| Fluoxetine | 19 | $231 | $12 |
| Allopurinol | 19 | $195 | $10 |
| Ibuprofen | 18 | $190 | $11 |
| Meloxicam | 37 | $179 | $5 |
| Lorazepam | 31 | $178 | $6 |
| Naproxen | 13 | $173 | $13 |
| Zolpidem | 17 | $118 | $7 |
| Omeprazole | 14 | $44 | $3 |
| Cyclobenzaprine | 12 | $27 | $2 |
| Escitalopram | 14 | $19 | $1 |
Year by year
| 2024 | 1,998 | 312 | 4% (84) | None | $611,693 |
| 2023 | 1,874 | 283 | 4% (80) | None | $718,465 |
| 2022 | 1,832 | 249 | 3% (55) | None | $744,501 |
| 2021 | 2,000 | 253 | 5% (96) | None | $618,590 |
| 2020 | 1,897 | 248 | 5% (103) | None | $686,873 |
| 2019 | 1,572 | 252 | 6% (92) | None | $566,639 |
| 2018 | 1,553 | 225 | 4% (69) | None | $492,200 |
| 2017 | 1,587 | 213 | 5% (73) | None | $430,204 |
| 2016 | 1,605 | 190 | 7% (108) | None | $418,665 |
| 2015 | 1,461 | 159 | 9% (127) | None | $385,820 |
| 2014 | 1,335 | 151 | 9% (113) | None | $238,903 |
| 2013 | 1,312 | 149 | 5% (69) | None | $203,353 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 32 drugs
| Enbrel Sureclick | 27 | $204,017 | $7,556 |
| Humira(Cf) | 12 | $184,183 | $15,349 |
| Xeljanz Xr | 12 | $64,517 | $5,376 |
| Tymlos | 18 | $52,686 | $2,927 |
| Hydroxychloroquine Sulfate | 303 | $20,356 | $67 |
| Restasis | 12 | $8,368 | $697 |
| Methotrexate | 169 | $8,158 | $48 |
| Celecoxib | 109 | $4,549 | $42 |
| Diclofenac | 82 | $3,056 | $37 |
| Prednisone | 237 | $2,738 | $12 |
| Leflunomide | 31 | $2,266 | $73 |
| Gabapentin | 91 | $2,200 | $24 |
| Pregabalin | 30 | $1,875 | $63 |
| Duloxetine | 59 | $1,722 | $29 |
| Sulfasalazine | 45 | $1,397 | $31 |
| Etodolac | 19 | $955 | $50 |
| Tramadol | 61 | $777 | $13 |
| Leucovorin | 22 | $657 | $30 |
| Allopurinol | 29 | $577 | $20 |
| Alendronate | 49 | $577 | $12 |
| Meloxicam | 36 | $439 | $12 |
| Methylprednisolone | 42 | $406 | $10 |
| Naproxen | 13 | $341 | $26 |
| Amitriptyline | 33 | $233 | $7 |
| Lorazepam | 26 | $202 | $8 |
| Zolpidem | 16 | $177 | $11 |
| Hydrocodone-Acetaminophen | 19 | $154 | $8 |
| Omeprazole | 19 | $150 | $8 |
| Folic Acid | 21 | $112 | $5 |
| Ibuprofen | 14 | $71 | $5 |
| Escitalopram | 17 | $60 | $4 |
| Fluoxetine | 15 | $41 | $3 |
2022: 32 drugs
| Enbrel Sureclick | 20 | $140,067 | $7,003 |
| Tymlos | 14 | $34,920 | $2,494 |
| Olumiant | 11 | $29,667 | $2,697 |
| Hydroxychloroquine Sulfate | 295 | $18,585 | $63 |
| Restasis | 14 | $12,419 | $887 |
| Methotrexate | 166 | $8,192 | $49 |
| Leflunomide | 49 | $5,114 | $104 |
| Celecoxib | 97 | $4,647 | $48 |
| Diclofenac | 74 | $3,024 | $41 |
| Prednisone | 222 | $2,524 | $11 |
| Pregabalin | 35 | $1,795 | $51 |
| Duloxetine | 56 | $1,709 | $31 |
| Gabapentin | 88 | $1,644 | $19 |
| Leucovorin | 32 | $1,093 | $34 |
| Sulfasalazine | 41 | $745 | $18 |
| Amitriptyline | 19 | $387 | $20 |
| Methylprednisolone | 39 | $367 | $9 |
| Tramadol | 40 | $359 | $9 |
| Allopurinol | 25 | $353 | $14 |
| Meloxicam | 51 | $352 | $7 |
| Alendronate | 49 | $351 | $7 |
| Fluoxetine | 18 | $348 | $19 |
| Naproxen | 25 | $347 | $14 |
| Omeprazole | 20 | $296 | $15 |
| Etodolac | 12 | $248 | $21 |
| Lorazepam | 16 | $164 | $10 |
| Ibuprofen | 21 | $161 | $8 |
| Hydrocodone-Acetaminophen | 14 | $138 | $10 |
| Folic Acid | 23 | $116 | $5 |
| Zolpidem | 19 | $84 | $4 |
| Escitalopram | 14 | $77 | $6 |
| Cyclobenzaprine | 11 | $34 | $3 |
2021: 33 drugs
| Enbrel Sureclick | 17 | $128,531 | $7,561 |
| Humira | 11 | $69,653 | $6,332 |
| Actemra | 11 | $50,576 | $4,598 |
| Olumiant | 12 | $30,310 | $2,526 |
| Hydroxychloroquine Sulfate | 330 | $25,896 | $78 |
| Restasis | 13 | $9,734 | $749 |
| Methotrexate | 160 | $9,497 | $59 |
| Celecoxib | 117 | $6,191 | $53 |
| Leflunomide | 44 | $4,531 | $103 |
| Prednisone | 278 | $3,439 | $12 |
| Diclofenac | 84 | $3,110 | $37 |
| Pregabalin | 26 | $2,362 | $91 |
| Duloxetine | 63 | $2,286 | $36 |
| Gabapentin | 120 | $2,197 | $18 |
| Sulfasalazine | 40 | $990 | $25 |
| Azathioprine | 12 | $651 | $54 |
| Nabumetone | 13 | $618 | $48 |
| Allopurinol | 36 | $610 | $17 |
| Amitriptyline | 42 | $495 | $12 |
| Tramadol | 72 | $488 | $7 |
| Naproxen | 22 | $485 | $22 |
| Alendronate | 53 | $466 | $9 |
| Etodolac | 11 | $395 | $36 |
| Omeprazole | 19 | $371 | $20 |
| Hydrocodone-Acetaminophen | 24 | $367 | $15 |
| Methylprednisolone | 26 | $336 | $13 |
| Lorazepam | 23 | $258 | $11 |
| Leucovorin | 14 | $193 | $14 |
| Meloxicam | 26 | $151 | $6 |
| Escitalopram | 15 | $89 | $6 |
| Zolpidem | 19 | $71 | $4 |
| Fluoxetine | 15 | $52 | $3 |
| Ibuprofen | 12 | $50 | $4 |
2020: 34 drugs
| Remicade | 13 | $44,543 | $3,426 |
| Hydroxychloroquine Sulfate | 262 | $28,332 | $108 |
| Tymlos | 12 | $22,865 | $1,905 |
| Restasis | 15 | $12,792 | $853 |
| Methotrexate | 117 | $8,529 | $73 |
| Leflunomide | 44 | $7,518 | $171 |
| Celecoxib | 76 | $5,116 | $67 |
| Diclofenac | 118 | $4,412 | $37 |
| Risedronate Sodium Dr | 18 | $3,579 | $199 |
| Prednisone | 265 | $2,966 | $11 |
| Pregabalin | 21 | $2,762 | $132 |
| Duloxetine | 74 | $2,703 | $37 |
| Gabapentin | 92 | $2,244 | $24 |
| Azathioprine | 22 | $1,849 | $84 |
| Sulfasalazine | 43 | $1,708 | $40 |
| Etodolac | 18 | $1,130 | $63 |
| Fluoxetine | 22 | $941 | $43 |
| Allopurinol | 36 | $785 | $22 |
| Tramadol | 87 | $557 | $6 |
| Naproxen | 24 | $459 | $19 |
| Alendronate | 51 | $435 | $9 |
| Amitriptyline | 36 | $412 | $11 |
| Methylprednisolone | 17 | $280 | $16 |
| Lorazepam | 23 | $279 | $12 |
| Leucovorin | 15 | $248 | $17 |
| Alprazolam | 14 | $229 | $16 |
| Nortriptyline | 19 | $218 | $11 |
| Omeprazole | 21 | $167 | $8 |
| Hydrocodone-Acetaminophen | 15 | $139 | $9 |
| Pantoprazole | 12 | $100 | $8 |
| Zolpidem | 23 | $91 | $4 |
| Clonazepam | 12 | $78 | $7 |
| Meloxicam | 19 | $72 | $4 |
| Escitalopram | 14 | $69 | $5 |
2019: 30 drugs
| Xeljanz Xr | 13 | $57,919 | $4,455 |
| Hydroxychloroquine Sulfate | 171 | $18,093 | $106 |
| Lyrica | 14 | $16,872 | $1,205 |
| Restasis | 12 | $9,140 | $762 |
| Methotrexate | 109 | $7,800 | $72 |
| Duloxetine | 91 | $6,578 | $72 |
| Leflunomide | 34 | $6,119 | $180 |
| Celecoxib | 66 | $4,362 | $66 |
| Risedronate Sodium Dr | 24 | $4,309 | $180 |
| Gabapentin | 81 | $2,864 | $35 |
| Diclofenac | 62 | $2,644 | $43 |
| Prednisone | 236 | $2,408 | $10 |
| Etodolac | 26 | $1,732 | $67 |
| Sulfasalazine | 44 | $1,235 | $28 |
| Azathioprine | 13 | $1,212 | $93 |
| Allopurinol | 32 | $686 | $21 |
| Tramadol | 63 | $599 | $10 |
| Alendronate | 37 | $422 | $11 |
| Methylprednisolone | 29 | $390 | $13 |
| Hydrocodone-Acetaminophen | 21 | $340 | $16 |
| Amitriptyline | 18 | $255 | $14 |
| Naproxen | 30 | $241 | $8 |
| Fluoxetine | 11 | $235 | $21 |
| Alprazolam | 12 | $231 | $19 |
| Nortriptyline | 19 | $200 | $11 |
| Lorazepam | 15 | $119 | $8 |
| Meloxicam | 18 | $102 | $6 |
| Methotrexate | 14 | $69 | $5 |
| Omeprazole | 14 | $60 | $4 |
| Zolpidem | 21 | $41 | $2 |
2018: 32 drugs
| Enbrel | 11 | $54,427 | $4,948 |
| Xeljanz Xr | 11 | $45,661 | $4,151 |
| Lyrica | 28 | $36,221 | $1,294 |
| Hydroxychloroquine Sulfate | 186 | $22,801 | $123 |
| Uloric | 24 | $10,362 | $432 |
| Methotrexate | 115 | $9,020 | $78 |
| Restasis | 12 | $8,202 | $684 |
| Duloxetine | 95 | $7,399 | $78 |
| Leflunomide | 31 | $7,100 | $229 |
| Celecoxib | 56 | $3,918 | $70 |
| Prednisone | 226 | $2,909 | $13 |
| Risedronate Sodium Dr | 14 | $2,637 | $188 |
| Diclofenac | 51 | $1,796 | $35 |
| Gabapentin | 91 | $1,668 | $18 |
| Etodolac | 20 | $1,665 | $83 |
| Azathioprine | 11 | $1,284 | $117 |
| Allopurinol | 39 | $927 | $24 |
| Sulfasalazine | 32 | $751 | $23 |
| Hydrocodone-Acetaminophen | 24 | $630 | $26 |
| Alendronate | 40 | $356 | $9 |
| Meloxicam | 29 | $291 | $10 |
| Amitriptyline | 30 | $272 | $9 |
| Fluoxetine | 21 | $266 | $13 |
| Naproxen | 23 | $265 | $12 |
| Tramadol | 45 | $201 | $4 |
| Methylprednisolone | 16 | $197 | $12 |
| Nortriptyline | 11 | $158 | $14 |
| Alprazolam | 13 | $112 | $9 |
| Zolpidem | 20 | $82 | $4 |
| Ibu | 11 | $75 | $7 |
| Methotrexate | 18 | $73 | $4 |
| Lorazepam | 12 | $24 | $2 |
2017: 32 drugs
| Humira | 14 | $62,166 | $4,440 |
| Xeljanz Xr | 13 | $50,279 | $3,868 |
| Lyrica | 29 | $26,452 | $912 |
| Hydroxychloroquine Sulfate | 160 | $25,394 | $159 |
| Methotrexate | 145 | $10,209 | $70 |
| Uloric | 17 | $7,725 | $454 |
| Duloxetine | 85 | $6,894 | $81 |
| Celecoxib | 22 | $4,976 | $226 |
| Leflunomide | 26 | $4,568 | $176 |
| Prednisone | 273 | $3,783 | $14 |
| Diclofenac | 68 | $2,647 | $39 |
| Azathioprine | 23 | $1,770 | $77 |
| Risedronate Sodium Dr | 12 | $1,491 | $124 |
| Etodolac | 17 | $1,461 | $86 |
| Allopurinol | 34 | $998 | $29 |
| Gabapentin | 67 | $958 | $14 |
| Hydrocodone-Acetaminophen | 31 | $855 | $28 |
| Sulfasalazine | 29 | $572 | $20 |
| Memantine | 13 | $521 | $40 |
| Alendronate | 49 | $407 | $8 |
| Amitriptyline | 19 | $250 | $13 |
| Naproxen | 30 | $248 | $8 |
| Nortriptyline | 15 | $243 | $16 |
| Leucovorin | 13 | $241 | $19 |
| Meloxicam | 32 | $240 | $7 |
| Tramadol | 34 | $215 | $6 |
| Eszopiclone | 12 | $206 | $17 |
| Trazodone | 27 | $168 | $6 |
| Methylprednisolone | 12 | $153 | $13 |
| Omeprazole | 13 | $128 | $10 |
| Zolpidem | 18 | $56 | $3 |
| Lorazepam | 13 | $28 | $2 |
2016: 36 drugs
| Enbrel | 20 | $159,973 | $7,999 |
| Humira | 22 | $88,026 | $4,001 |
| Orencia | 13 | $35,949 | $2,765 |
| Hydroxychloroquine Sulfate | 162 | $27,671 | $171 |
| Methotrexate | 144 | $11,174 | $78 |
| Leflunomide | 23 | $8,318 | $362 |
| Duloxetine | 66 | $6,734 | $102 |
| Colchicine | 19 | $5,139 | $270 |
| Celecoxib | 33 | $4,043 | $123 |
| Prednisone | 247 | $3,514 | $14 |
| Etodolac | 24 | $1,990 | $83 |
| Voltaren | 23 | $1,895 | $82 |
| Risedronate Sodium Dr | 13 | $1,730 | $133 |
| Oxycodone-Acetaminophen | 17 | $1,619 | $95 |
| Diclofenac | 41 | $1,410 | $34 |
| Azathioprine | 31 | $1,132 | $37 |
| Fentanyl | 13 | $944 | $73 |
| Hydrocodone-Acetaminophen | 29 | $909 | $31 |
| Gabapentin | 62 | $839 | $14 |
| Allopurinol | 53 | $705 | $13 |
| Amitriptyline | 37 | $548 | $15 |
| Methylprednisolone | 23 | $414 | $18 |
| Sulfasalazine | 12 | $298 | $25 |
| Tramadol | 44 | $285 | $6 |
| Alendronate | 31 | $257 | $8 |
| Leucovorin | 13 | $229 | $18 |
| Nortriptyline | 17 | $217 | $13 |
| Eszopiclone | 13 | $197 | $15 |
| Naproxen | 22 | $192 | $9 |
| Omeprazole | 19 | $174 | $9 |
| Zolpidem | 25 | $171 | $7 |
| Meloxicam | 30 | $131 | $4 |
| Trazodone | 14 | $125 | $9 |
| Fluticasone Propionate | 12 | $111 | $9 |
| Ibuprofen | 12 | $75 | $6 |
| Lorazepam | 13 | $34 | $3 |
2015: 31 drugs
| Enbrel | 36 | $198,780 | $5,522 |
| Humira | 15 | $49,437 | $3,296 |
| Hydroxychloroquine Sulfate | 134 | $25,975 | $194 |
| Methotrexate | 108 | $11,982 | $111 |
| Duloxetine | 75 | $8,030 | $107 |
| Celecoxib | 28 | $5,682 | $203 |
| Lyrica | 11 | $4,728 | $430 |
| Uloric | 11 | $4,644 | $422 |
| Leflunomide | 18 | $4,027 | $224 |
| Colchicine | 16 | $3,831 | $239 |
| Savella | 16 | $3,630 | $227 |
| Prednisone | 232 | $3,484 | $15 |
| Voltaren | 24 | $1,966 | $82 |
| Etodolac | 21 | $1,842 | $88 |
| Oxycodone-Acetaminophen | 15 | $1,814 | $121 |
| Fentanyl | 18 | $1,525 | $85 |
| Azathioprine | 32 | $1,134 | $35 |
| Hydrocodone-Acetaminophen | 26 | $799 | $31 |
| Gabapentin | 46 | $745 | $16 |
| Allopurinol | 61 | $728 | $12 |
| Sulfasalazine | 14 | $603 | $43 |
| Amitriptyline | 26 | $322 | $12 |
| Eszopiclone | 13 | $317 | $24 |
| Alendronate | 40 | $314 | $8 |
| Omeprazole | 21 | $313 | $15 |
| Tramadol | 57 | $254 | $4 |
| Methylprednisolone | 12 | $231 | $19 |
| Zolpidem | 18 | $174 | $10 |
| Naproxen | 21 | $163 | $8 |
| Meloxicam | 26 | $143 | $5 |
| Trazodone | 13 | $68 | $5 |
2014: 30 drugs
| Enbrel | 36 | $131,326 | $3,648 |
| Duloxetine | 65 | $14,741 | $227 |
| Celebrex | 34 | $13,416 | $395 |
| Methotrexate | 103 | $11,224 | $109 |
| Lidocaine | 12 | $7,341 | $612 |
| Uloric | 14 | $4,920 | $351 |
| Hydroxychloroquine Sulfate | 139 | $4,693 | $34 |
| Lunesta | 12 | $3,818 | $318 |
| Prednisone | 241 | $3,510 | $15 |
| Voltaren | 20 | $1,682 | $84 |
| Trexall | 12 | $1,627 | $136 |
| Leflunomide | 23 | $1,498 | $65 |
| Etodolac | 15 | $1,494 | $100 |
| Oxycodone-Acetaminophen | 11 | $1,429 | $130 |
| Fentanyl | 13 | $1,236 | $95 |
| Diclofenac | 22 | $871 | $40 |
| Azathioprine | 25 | $853 | $34 |
| Hydrocodone-Acetaminophen | 38 | $823 | $22 |
| Sulfasalazine | 12 | $522 | $44 |
| Alendronate | 67 | $475 | $7 |
| Allopurinol | 48 | $341 | $7 |
| Gabapentin | 17 | $321 | $19 |
| Ciprofloxacin | 18 | $243 | $14 |
| Meloxicam | 32 | $220 | $7 |
| Tramadol | 34 | $180 | $5 |
| Leucovorin | 11 | $172 | $16 |
| Naproxen | 17 | $166 | $10 |
| Zolpidem | 18 | $96 | $5 |
| Omeprazole | 12 | $94 | $8 |
| Amitriptyline | 17 | $86 | $5 |
2013: 25 drugs
| Enbrel | 37 | $110,889 | $2,997 |
| Cymbalta | 55 | $13,945 | $254 |
| Celebrex | 38 | $12,134 | $319 |
| Methotrexate | 112 | $10,441 | $93 |
| Lidoderm | 13 | $6,049 | $465 |
| Hydroxychloroquine Sulfate | 135 | $2,885 | $21 |
| Prednisone | 250 | $2,360 | $9 |
| Leflunomide | 25 | $2,181 | $87 |
| Uloric | 11 | $2,179 | $198 |
| Gabapentin | 50 | $1,949 | $39 |
| Trexall | 13 | $1,570 | $121 |
| Voltaren | 12 | $1,124 | $94 |
| Azathioprine | 24 | $806 | $34 |
| Diclofenac | 29 | $764 | $26 |
| Alendronate | 45 | $465 | $10 |
| Hydrocodone-Acetaminophen | 35 | $376 | $11 |
| Sulfasalazine | 15 | $369 | $25 |
| Allopurinol | 54 | $349 | $6 |
| Methylprednisolone | 13 | $301 | $23 |
| Ciprofloxacin | 15 | $271 | $18 |
| Naproxen | 17 | $226 | $13 |
| Tramadol | 16 | $125 | $8 |
| Ibuprofen | 15 | $107 | $7 |
| Meloxicam | 11 | $96 | $9 |
| Amitriptyline | 14 | $68 | $5 |
Money from drug and device companies
$3,087 in 2025
| 2025 | 27 | 131 | None | $3,087 |
| 2024 | 25 | 158 | None | $3,520 |
| 2023 | 16 | 140 | None | $2,868 |
| 2022 | 19 | 150 | None | $2,772 |
| 2021 | 6 | 25 | None | $514 |
| 2020 | 13 | 31 | None | $566 |
| 2019 | 21 | 173 | None | $3,020 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Skyrizi | $644 | 24 payments
|
| Novartis Pharmaceuticals | Cosentyx | $398 | 17 payments
|
| Janssen Biotech | Tremfya | $344 | 10 payments
|
| Amgen | Evenity | $324 | 23 payments
|
| GlaxoSmithKline | Benlysta | $207 | 7 payments
|
| Lilly USA | Taltz | $205 | 7 payments
|
See all 131 published payments
| Ucb | Meals · 2025-12-24 | Bimzelx | $47 |
| Abbvie | Meals · 2025-12-22 | Rinvoq | $30 |
| ANI Pharmaceuticals | Meals · 2025-12-18 | Sovuna | $15 |
| Abbvie | Meals · 2025-12-16 | Skyrizi | $29 |
| Amgen | Meals · 2025-12-16 | Enbrel | $5 |
| Tonix Medicines | Meals · 2025-12-12 | Tonmya | $20 |
| Novartis Pharmaceuticals | Meals · 2025-12-10 | Cosentyx | $16 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-12-09 | Jascayd | $25 |
| Janssen Biotech | Meals · 2025-12-02 | Tremfya | $36 |
| Janssen Biotech | Meals · 2025-12-02 | Tremfya | $3 |
| Fresenius Kabi USA | Meals · 2025-11-24 | None | $28 |
| Janssen Biotech | Meals · 2025-11-17 | Tremfya | $31 |
| Radius Health | Meals · 2025-11-17 | Tymlos | $30 |
| Genentech USA | Meals · 2025-11-04 | Gazyva | $26 |
| GlaxoSmithKline | Meals · 2025-11-03 | Benlysta | $33 |
| Novo Nordisk | Meals · 2025-10-30 | Ozempic | $16 |
| Abbvie | Meals · 2025-10-27 | Skyrizi | $28 |
| Amgen | Meals · 2025-10-27 | Enbrel | $7 |
| Janssen Biotech | Education · 2025-10-23 | Tremfya | $99 |
| Fresenius Kabi USA | Meals · 2025-10-22 | None | $30 |
| Amgen | Meals · 2025-10-21 | Evenity | $25 |
| Janssen Biotech | Meals · 2025-10-14 | Tremfya | $11 |
| Abbvie | Meals · 2025-10-13 | Rinvoq | $26 |
| Amgen | Meals · 2025-10-13 | Enbrel | $6 |
| Abbvie | Meals · 2025-10-07 | Rinvoq | $30 |
| Novartis Pharmaceuticals | Meals · 2025-10-06 | Ilaris | $24 |
| Abbvie | Meals · 2025-09-30 | Skyrizi | $25 |
| Organon | Meals · 2025-09-30 | Hadlima | $18 |
| Janssen Biotech | Meals · 2025-09-29 | Tremfya | $7 |
| Amgen | Meals · 2025-09-29 | Enbrel | $6 |
| Lilly USA | Meals · 2025-09-15 | Taltz | $25 |
| Abbvie | Meals · 2025-09-10 | Rinvoq | $25 |
| Pfizer | Meals · 2025-09-09 | Xeljanz | $1 |
| Novartis Pharmaceuticals | Meals · 2025-09-08 | Cosentyx | $22 |
| Pfizer | Meals · 2025-09-08 | Xeljanz | $29 |
| Amgen | Meals · 2025-09-04 | Evenity | $16 |
| Novartis Pharmaceuticals | Meals · 2025-08-29 | Cosentyx | $23 |
| Novartis Pharmaceuticals | Meals · 2025-08-26 | Ilaris | $25 |
| Amgen | Meals · 2025-08-26 | Enbrel | $5 |
| Abbvie | Meals · 2025-08-25 | Skyrizi | $32 |
| Lilly USA | Meals · 2025-08-19 | Taltz | $25 |
| Octapharma USA | Meals · 2025-08-19 | Octagam Immune Globulin (Human) | $17 |
| Exact Sciences | Meals · 2025-08-14 | Cologuard Collection Kit | $17 |
| Novartis Pharmaceuticals | Meals · 2025-08-13 | Cosentyx | $28 |
| Abbvie | Meals · 2025-08-12 | Skyrizi | $34 |
| Pfizer | Meals · 2025-08-11 | Xeljanz | $16 |
| Janssen Biotech | Meals · 2025-08-08 | Tremfya | $5 |
| GlaxoSmithKline | Meals · 2025-07-31 | Benlysta | $26 |
| Abbvie | Meals · 2025-07-29 | Skyrizi | $32 |
| Amgen | Meals · 2025-07-29 | Enbrel | $2 |
| Ucb | Meals · 2025-07-22 | Bimzelx | $14 |
| Novartis Pharmaceuticals | Meals · 2025-07-21 | Cosentyx | $25 |
| Abbvie | Meals · 2025-07-17 | Skyrizi | $21 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-11 | Saphnelo | $27 |
| Abbvie | Meals · 2025-07-08 | Skyrizi | $31 |
| Pfizer | Meals · 2025-07-08 | Xeljanz | $20 |
| Organon | Meals · 2025-06-30 | Hadlima | $19 |
| Amgen | Meals · 2025-06-24 | Enbrel | $4 |
| Merck Sharp & Dohme | Meals · 2025-06-24 | Winrevair | $34 |
| Abbvie | Meals · 2025-06-23 | Skyrizi | $8 |
| Novartis Pharmaceuticals | Meals · 2025-06-20 | Cosentyx | $31 |
| Octapharma USA | Meals · 2025-06-20 | Octagam Immune Globulin (Human) | $27 |
| GlaxoSmithKline | Meals · 2025-06-17 | Benlysta | $18 |
| Mallinckrodt Hospital Products | Meals · 2025-06-16 | Acthar | $33 |
| Novartis Pharmaceuticals | Meals · 2025-06-13 | Ilaris | $23 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-13 | Saphnelo | $14 |
| Novartis Pharmaceuticals | Meals · 2025-06-12 | Cosentyx | $21 |
| Abbvie | Meals · 2025-06-11 | Rinvoq | $30 |
| Amgen | Meals · 2025-06-10 | Evenity | $20 |
| Merck Sharp & Dohme | Meals · 2025-06-06 | Winrevair | $35 |
| Abbvie | Meals · 2025-06-04 | Skyrizi | $33 |
| Abbvie | Meals · 2025-05-27 | Skyrizi | $13 |
| Lilly USA | Meals · 2025-05-22 | Taltz | $32 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-05-21 | Orencia | $20 |
| GlaxoSmithKline | Meals · 2025-05-20 | Benlysta | $31 |
| Sandoz | Meals · 2025-05-19 | Hyrimoz | $23 |
| Abbvie | Meals · 2025-05-17 | Skyrizi | $36 |
| Pfizer | Meals · 2025-05-17 | Xeljanz | $23 |
| Novartis Pharmaceuticals | Meals · 2025-05-15 | Cosentyx | $18 |
| Abbvie | Meals · 2025-05-13 | Skyrizi | $17 |
| Amgen | Meals · 2025-05-12 | Enbrel | $2 |
| Novartis Pharmaceuticals | Meals · 2025-05-09 | Cosentyx | $24 |
| Novartis Pharmaceuticals | Meals · 2025-05-09 | Cosentyx | $30 |
| Amgen | Meals · 2025-05-07 | Uplizna | $33 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-05-06 | Ofev | $21 |
| Abbvie | Meals · 2025-05-04 | Rinvoq | $29 |
| Janssen Biotech | Education · 2025-04-30 | Tremfya | $100 |
| Amgen | Meals · 2025-04-28 | Enbrel | $4 |
| Radius Health | Meals · 2025-04-25 | Tymlos | $34 |
| Abbvie | Meals · 2025-04-24 | Rinvoq | $21 |
| Amgen | Meals · 2025-04-24 | Tavneos | $6 |
| Lilly USA | Meals · 2025-04-22 | Taltz | $32 |
| Pfizer | Meals · 2025-04-21 | Xeljanz | $19 |
| GlaxoSmithKline | Meals · 2025-04-15 | Benlysta | $30 |
| Mallinckrodt Hospital Products | Meals · 2025-04-10 | Acthar | $16 |
| Alvogen | Meals · 2025-04-08 | Teriparatide | $28 |
| ANI Pharmaceuticals | Meals · 2025-04-08 | Sovuna | $14 |
| Amgen | Meals · 2025-04-04 | Uplizna | $28 |
| Abbvie | Meals · 2025-04-02 | Rinvoq | $32 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-03-31 | Orencia | $25 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-29 | Saphnelo | $17 |
| Amgen | Meals · 2025-03-28 | Krystexxa | $21 |
| Janssen Biotech | Meals · 2025-03-27 | Tremfya | $19 |
| Amgen | Meals · 2025-03-26 | None | $28 |
| GlaxoSmithKline | Meals · 2025-03-25 | Benlysta | $34 |
| Abbvie | Meals · 2025-03-24 | Rinvoq | $28 |
| Amgen | Meals · 2025-03-20 | Evenity | $20 |
| Lilly USA | Meals · 2025-03-18 | Taltz | $32 |
| Pfizer | Meals · 2025-03-17 | Xeljanz | $26 |
| Sobi | Meals · 2025-03-13 | Gamifant | $20 |
| Novartis Pharmaceuticals | Meals · 2025-03-06 | Cosentyx | $24 |
| Amgen | Meals · 2025-03-04 | Enbrel | $6 |
| Scilex Pharmaceuticals | Meals · 2025-02-28 | Ztlido | $20 |
| Amgen | Meals · 2025-02-25 | None | $28 |
| Lilly USA | Meals · 2025-02-18 | Taltz | $31 |
| Amgen | Meals · 2025-02-17 | Evenity | $15 |
| Novartis Pharmaceuticals | Meals · 2025-02-12 | Cosentyx | $23 |
| Novartis Pharmaceuticals | Meals · 2025-02-12 | Cosentyx | $20 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-02-07 | Orencia | $22 |
| Janssen Biotech | Meals · 2025-02-06 | Tremfya | $32 |
| Abbvie | Meals · 2025-02-03 | Rinvoq | $20 |
| Aurinia Pharma U.S. | Meals · 2025-01-31 | Lupkynis | $16 |
| Organon | Meals · 2025-01-30 | Hadlima | $22 |
| Amgen | Meals · 2025-01-29 | None | $29 |
| Radius Health | Meals · 2025-01-27 | Tymlos | $24 |
| GlaxoSmithKline | Meals · 2025-01-23 | Benlysta | $34 |
| Amgen | Meals · 2025-01-23 | Enbrel | $8 |
| Novartis Pharmaceuticals | Meals · 2025-01-21 | Cosentyx | $21 |
| Abbvie | Meals · 2025-01-13 | Rinvoq | $33 |
| Lilly USA | Meals · 2025-01-07 | Taltz | $27 |
| Pfizer | Meals · 2025-01-06 | Xeljanz | $17 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $3,520
| Amgen | Enbrel | $843 | 41 payments
|
| Abbvie | Rinvoq | $546 | 24 payments
|
| Janssen Biotech | Tremfya | $302 | 13 payments
|
| Novartis Pharmaceuticals | Cosentyx | $280 | 13 payments
|
| Lilly USA | Taltz | $252 | 8 payments
|
| GlaxoSmithKline | Benlysta | $220 | 8 payments
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $149 | 7 payments
|
| Fresenius Kabi USA | None | $111 | 4 payments
|
| Radius Health | Tymlos | $102 | 5 payments
|
| Pfizer | Xeljanz | $92 | 5 payments
|
| E.R. Squibb & Sons L.L.C. | Orencia | $87 | 3 payments
|
| Alexion Pharmaceuticals | Strensiq | $72 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Saphnelo | $62 | 3 payments
|
| Ucb | Cimzia | $59 | 2 payments
|
| Organon | Hadlima | $51 | 3 payments
|
| Teva Pharmaceuticals USA | None | $48 | 2 payments
|
| Scilex Pharmaceuticals | Ztlido | $44 | 2 payments
|
| ANI Pharmaceuticals | Purified Cortrophin Gel | $41 | 2 payments
|
| Alvogen | Teriparatide | $36 | 2 payments
|
| Sandoz | Hyrimoz | $27 | 1 payment
|
| Kyowa Kirin | None | $24 | 1 payment
|
| Aurinia Pharma U.S. | Lupkynis | $23 | 1 payment
|
| Mallinckrodt Hospital Products | Acthar | $18 | 1 payment
|
| Genentech USA | Actemra | $16 | 1 payment
|
| Octapharma USA | Octagam Immune Globulin (Human) | $16 | 1 payment
|
2023: $2,868
| AbbVie | Rinvoq | $1,022 | 50 payments
|
| Amgen | Enbrel | $632 | 33 payments
|
| Ucb | Cimzia | $259 | 13 payments
|
| Novartis Pharmaceuticals | Cosentyx | $158 | 8 payments
|
| GlaxoSmithKline | Benlysta | $149 | 5 payments
|
| Lilly USA | Taltz | $111 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Saphnelo | $100 | 5 payments
|
| Boehringer Ingelheim Pharmaceuticals | Cyltezo | $95 | 5 payments
|
| Janssen Biotech | Tremfya | $75 | 4 payments
|
| Pfizer | Xeljanz | $67 | 3 payments
|
| Horizon Therapeutics plc | Krystexxa | $51 | 3 payments
|
| Aurinia Pharma U.S. | Lupkynis | $44 | 2 payments
|
| Radius Health | Tymlos | $41 | 2 payments
|
| Fresenius Kabi USA | None | $30 | 1 payment
|
| Alvogen | Teriparatide | $19 | 1 payment
|
| Ferring Pharmaceuticals | Euflexxa | $15 | 1 payment
|
2022: $2,772
| Abbvie | Rinvoq | $696 | 38 payments
|
| Amgen | Enbrel | $538 | 31 payments
|
| Novartis Pharmaceuticals | Cosentyx | $181 | 10 payments
|
| Lilly USA | Taltz | $172 | 7 payments
|
| Pfizer | Xeljanz | $171 | 8 payments
|
| GlaxoSmithKline | Benlysta | $167 | 10 payments
|
| Janssen Biotech | Remicade | $166 | 11 payments
|
| AstraZeneca Pharmaceuticals LP | Saphnelo | $142 | 8 payments
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $98 | 5 payments
|
| Horizon Therapeutics plc | Krystexxa | $89 | 5 payments
|
| Ucb | Cimzia | $87 | 3 payments
|
| Sobi | Kineret | $62 | 3 payments
|
| Radius Health | Tymlos | $46 | 2 payments
|
| Aurinia Pharma U.S. | Lupkynis | $45 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Orencia | $40 | 2 payments
|
| Hikma Pharmaceuticals USA | Mitigare | $27 | 2 payments
|
| Ferring Pharmaceuticals | Euflexxa | $22 | 1 payment
|
| Fidia Pharma USA | Hymovis | $13 | 1 payment
|
| Cumberland Pharmaceuticals | Reditrex | $12 | 1 payment
|
2021: $514
| Amgen | Enbrel | $190 | 12 payments
|
| GlaxoSmithKline | Benlysta | $132 | 3 payments
|
| AbbVie | Rinvoq | $82 | 5 payments
|
| Novartis Pharmaceuticals | Cosentyx | $46 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Saphnelo | $39 | 2 payments
|
| Ucb | Cimzia | $26 | 1 payment
|
2020: $566
| Amgen | Enbrel | $115 | 9 payments
|
| Novartis Pharmaceuticals | Cosentyx | $96 | 5 payments
|
| Lilly USA | Taltz | $71 | 3 payments
|
| AbbVie | Rinvoq | $63 | 3 payments
|
| Ucb | Cimzia | $41 | 2 payments
|
| GlaxoSmithKline | Benlysta | $34 | 2 payments
|
| Pfizer | Xeljanz | $28 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $28 | 1 payment
|
| Radius Health | Tymlos | $25 | 1 payment
|
| Horizon Therapeutics plc | Krystexxa | $17 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Orencia | $17 | 1 payment
|
| Genzyme | Kevzara | $17 | 1 payment
|
| Antares Pharma | Otrexup | $13 | 1 payment
|
2019: $3,020
| Amgen | Enbrel | $531 | 24 payments
|
| Novartis Pharmaceuticals | Cosentyx | $468 | 29 payments
|
| Pfizer | Xeljanz | $344 | 27 payments
|
| AbbVie | Humira | $305 | 16 payments
|
| Ucb | Cimzia | $250 | 9 payments
|
| Celgene | Otezla | $224 | 14 payments
|
| GlaxoSmithKline | Benlysta | $192 | 12 payments
|
| Lilly USA | Taltz | $185 | 10 payments
|
| Medexus Pharma | Rasuvo | $108 | 8 payments
|
| E.R. Squibb & Sons L.L.C. | Orencia | $88 | 6 payments
|
| Horizon Therapeutics plc | Rayos | $75 | 4 payments
|
| Sobi | Kineret | $55 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $42 | 2 payments
|
| Genentech USA | Rituxan | $39 | 2 payments
|
| Alexion Pharmaceuticals | Strensiq | $24 | 1 payment
|
| Genzyme | Kevzara | $20 | 1 payment
|
| Ferring Pharmaceuticals | Euflexxa | $17 | 1 payment
|
| Sanofi-Aventis U.S. | Synvisc-One | $14 | 1 payment
|
| Arbor Pharmaceuticals | Horizant | $14 | 1 payment
|
| Gilead Sciences | None | $12 | 1 payment
|
| Antares Pharma | Xyosted | $12 | 1 payment
|
Professional record
- NPI
- 1356469266
- Licence
- CA A86522California A86522: Current · expires 2028-04-30
- Trained
- Jefferson Medical College of Thomas Jefferson University, 2002
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A865220
- Taxonomy
- Federal specialty code 207RR0500X (207RR0500X)
- Mailing address
- 26522 La Alameda, Suite 120, Mission Viejo, CA, 92691
- NPI first listed
- 2007-03-27
- NPI last updated
- 2021-10-21
- NPI record certified
- 2021-10-21
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 26800 Crown Valley Pkwy, Mission Viejo, CA, 92691
This office lists an electronic records connection.